Success of Current COVID-19 Vaccine Strategies vs. the Epitope Topology of SARS-CoV-2 Spike Protein-Receptor Binding Domain (RBD): A Computational Study of RBD Topology to Guide Future Vaccine Design (original) (raw)

Variety of Spike Protein in COVID-19 Mutation: Stability, Effectiveness and Outbreak Rate as a Target for Vaccine and Therapeutic Development

azam ghadami

Biointerface Research in Applied Chemistry, 2020

View PDFchevron_right

Computational Analysis of Mutations in the Receptor-Binding Domain of SARS-CoV-2 Spike and Their Effects on Antibody Binding

Konstantin Shaitan

Viruses

View PDFchevron_right

Uncovering the impact of SARS-CoV2 spike protein variants on human receptors: A molecular dynamics docking and simulation approach

Nouman Ali

2023

View PDFchevron_right

In Silico Approach to Construct the 3D Structures of Spike Glycoproteins of Novel Variants of Severe Acute Respiratory Syndrome Coronavirus 2

Dr. Shalini Swami

Zenodo (CERN European Organization for Nuclear Research), 2023

View PDFchevron_right

SARS-CoV-2 mutations and where to find them: an in silico perspective of structural changes and antigenicity of the spike protein

Ubiratan Batista

Journal of biomolecular structure & dynamics, 2020

View PDFchevron_right

Mutational landscape and in silico structure models of SARS-CoV-2 spike receptor binding domain reveal key molecular determinants for virus-host interaction

Roshny Prasad

BMC Molecular and Cell Biology, 2022

View PDFchevron_right

SARS-CoV-2 Spike Protein Mutations and Escape from Antibodies: A Computational Model of Epitope Loss in Variants of Concern

Silvia Pavoni

Journal of Chemical Information and Modeling

View PDFchevron_right

Multi-epitope Subunit Vaccine Design against COVID-19 Based on the Spike Protein of SARS-CoV-2: An In Silico Analysis

Kruapnidhi Sreerama

View PDFchevron_right

Using In Silico Bioinformatics Algorithms for the Accurate Prediction of the Impact of Spike Protein Mutations on the Pathogenicity, Stability, and Functionality of the SARS-CoV-2 Virus and Analysis of Potential Therapeutic Targets

negin alizadeh

Biochemical Genetics

View PDFchevron_right

High-Resolution Linear Epitope Mapping of the Receptor Binding Domain of SARS-CoV-2 Spike Protein in COVID-19 mRNA Vaccine Recipients

Katherine Candray

Microbiology spectrum, 2021

View PDFchevron_right

Exploring the SARS-CoV-2 structural proteins for multi-epitope vaccine development: an in-silico approach

udit saumya

Expert Review of Vaccines, 2020

View PDFchevron_right

Mutations in Spike Protein of SARS-CoV-2 Modulate Receptor Binding, Membrane Fusion and Immunogenicity: An Insight into Viral Tropism and Pathogenesis of COVID-19

Ranabir Majumder

View PDFchevron_right

Computational perspectives revealed prospective vaccine candidates from five structural proteins of novel SARS corona virus 2019 (SARS-CoV-2)

subham biswal

PeerJ

View PDFchevron_right

Computational simulation of interactions between SARS coronavirus spike mutants and host species-specific receptors

Masami Hasegawa

Computational Biology and Chemistry, 2007

View PDFchevron_right

Structural basis to design multi-epitope vaccines against Novel Coronavirus 19 (COVID19) infection, the ongoing pandemic emergency: an in silico approach

mohit kamthania

View PDFchevron_right

Structural and energetic profiling of SARS-CoV-2 antibody recognition and the impact of circulating variants

Ghazaleh Taherzadeh

2021

View PDFchevron_right

In silico analysis of SARS-CoV-2 spike glycoprotein and insights into antibody binding

Victor Padilla-Sanchez, PhD

Research Ideas and Outcomes

View PDFchevron_right

Mutational analysis of the spike protein of SARS-COV-2 isolates revealed atomistic features responsible for higher binding and infectivity

Muqaddas Fatima

Frontiers in Cell and Developmental Biology

View PDFchevron_right

In silico Antibody Mutagenesis for Optimizing its Binding to the Spike Protein of SARS-CoV-2

Binquan Luan

2020

View PDFchevron_right

Homology Modeling and Molecular Dynamics-Driven Search for Natural Inhibitors That Universally Target Receptor-Binding Domain of Spike Glycoprotein in SARS-CoV-2 Variants

Wojciech Kolodziejczyk

Molecules

View PDFchevron_right

In Silico Comparative Analysis of the Functional, Structural, and Evolutionary Properties of SARS-CoV-2 Variant Spike Proteins

Palaksha K. Javaregowda

JMIR Bioinformatics and Biotechnology

View PDFchevron_right

Unraveling the stability landscape of mutations in the SARS-CoV-2 receptor-binding domain

Hamdi Yahyaoui

Scientific Reports, 2021

View PDFchevron_right

Predicted structural mimicry of spike receptor-binding motifs from highly pathogenic human coronaviruses

Tom Blundell

2021

View PDFchevron_right

Targeting Receptor Binding Domain and Cryptic Pocket of Spike glycoprotein from SARS-CoV-2 by biomolecular modeling

Frida Sosa Amay

arXiv: Biomolecules, 2020

View PDFchevron_right

Molecular characterization, pathogen-host interaction pathway and in silico approaches for vaccine design against COVID-19

Mohan Singh

Journal of Chemical Neuroanatomy, 2020

View PDFchevron_right

Bioinformatics Analysis of SARS-CoV-2 to Approach an Effective Vaccine Candidate Against COVID-19

golnaz bahramali

Molecular Biotechnology, 2021

View PDFchevron_right

In silico design of Multi-epitope-based peptide vaccine against SARS-CoV-2 using its spike protein

Janmejay Pandey

View PDFchevron_right

Identification of a Potent Inhibitor Targeting the Spike Protein of Pandemic Human Coronavirus, SARS-CoV-2 by Computational Methods

Sruthi Unni

View PDFchevron_right

Mutational analysis in international isolates and drug repurposing against SARS-CoV-2 spike protein: molecular docking and simulation approach

Meena Pal

VirusDisease, 2021

View PDFchevron_right

Functional and Structural Characterization of SARS-Cov-2 Spike Protein: An In Silico Study

Meysam Hasannejad-Bibalan

Ethiopian Journal of Health Sciences

View PDFchevron_right

Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants

Krishna Anand

2021

View PDFchevron_right

Distinct evolution of infection-enhancing and neutralizing epitopes in the spike protein of SARS-CoV-2 variants (alpha, beta, gamma, delta, lambda and mu) : a structural and molecular epidemiology study

Jacques Fantini

2021

View PDFchevron_right